Skip to content

Slow progress in diagnosis and treatment of MDR-TB and XDR-TB

Isoniazid and ARVs reduce TB risk by 90% in two South African clinics

High rate of anal HPV infection, low rate of clearance and significant new infections in HIV-positive gay men

New UN drug policy will undermine HIV prevention

Drug resistance tests recommended for patients with suspected TB IRIS

Low HDL cholesterol linked to cardiovascular disease in people with HIV

Sweet sorrow: diabetes and HIV

Breakthrough in XDR-TB research could lead to two-drug treatment

HIV doesn't increase risk of melanoma, but immune suppression associated with risk of rarer skin cancers